Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Cheng Jing

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Zhonghua Xin Xue Guan Bing Za Zhi|February 11, 2012
[Enhance specialist training and improve the capabilities of management on pulmonary vascular diseases in China]Zhi-cheng Jing
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 12, 2007
[The current situation and strategies in management of pulmonary arterial hypertension in China]Zhi-Cheng Jing
Chronic Diseases and Translational Medicine|December 18, 2020
Inflammation and cardiovascular diseasesHui Wang, Zhi-Cheng Jing
Current Hypertension Reports|October 12, 2013
Epidemiology of pulmonary arterial hypertensionXin Jiang, Zhi-Cheng Jing
Zhonghua Xin Xue Guan Bing Za Zhi|February 14, 2008
[The progress in genetics of pulmonary arterial hypertension]Wei Zhang, Zhi-Cheng Jing
Zhonghua Xin Xue Guan Bing Za Zhi|September 5, 2012
[Sleep apnea syndrome and pulmonary hypertension]Lu Yang, Zhi-cheng Jing
Journal of Thrombosis and Haemostasis : JTH|July 21, 2022
Statin therapy in venous thromboembolism: How far from primary and secondary prevention?Rong Jiang, Zhi-Cheng Jing
International Journal of Cardiology|December 3, 2014
Isoprostane as a promising biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints. Response to letter to the editorRui Zhang, Zhi-Cheng Jing
Current Pharmaceutical Design|June 17, 2016
Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular RemodelingRui Zhang, Zhi-Cheng Jing
Asiaintervention|March 31, 2022
Beyond medications: is pulmonary artery denervation the answer for pulmonary arterial hypertension?: PADN for PAHFan Guo, Zhi-Cheng Jing
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Zhonghua Xin Xue Guan Bing Za Zhi|February 11, 2012
[Enhance specialist training and improve the capabilities of management on pulmonary vascular diseases in China]Zhi-cheng Jing
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 12, 2007
[The current situation and strategies in management of pulmonary arterial hypertension in China]Zhi-Cheng Jing
Chronic Diseases and Translational Medicine|December 18, 2020
Inflammation and cardiovascular diseasesHui Wang, Zhi-Cheng Jing
Current Hypertension Reports|October 12, 2013
Epidemiology of pulmonary arterial hypertensionXin Jiang, Zhi-Cheng Jing
Zhonghua Xin Xue Guan Bing Za Zhi|February 14, 2008
[The progress in genetics of pulmonary arterial hypertension]Wei Zhang, Zhi-Cheng Jing
Zhonghua Xin Xue Guan Bing Za Zhi|September 5, 2012
[Sleep apnea syndrome and pulmonary hypertension]Lu Yang, Zhi-cheng Jing
Journal of Thrombosis and Haemostasis : JTH|July 21, 2022
Statin therapy in venous thromboembolism: How far from primary and secondary prevention?Rong Jiang, Zhi-Cheng Jing
International Journal of Cardiology|December 3, 2014
Isoprostane as a promising biomarker in pulmonary arterial hypertension: preanalytical and analytical viewpoints. Response to letter to the editorRui Zhang, Zhi-Cheng Jing
Current Pharmaceutical Design|June 17, 2016
Energetic Metabolic Roles in Pulmonary Arterial Hypertension and Right Ventricular RemodelingRui Zhang, Zhi-Cheng Jing
Asiaintervention|March 31, 2022
Beyond medications: is pulmonary artery denervation the answer for pulmonary arterial hypertension?: PADN for PAHFan Guo, Zhi-Cheng Jing
Pageof 22